< ARTIVION Corporate Site
< ARTIVION Corporate Site

CryoLife, Inc. Announces Conference Call at 4:00 PM Today

August 14, 2002 at 1:48 PM EDT
PDF Version
ATLANTA, Aug 14, 2002 /PRNewswire-FirstCall via COMTEX/ -- CryoLife, Inc. (NYSE: CRY), a life-science company involved in the development and commercialization of cryopreserved and tissue-engineered implantable heart valves, vascular and orthopaedic grafts, and surgical adhesives, will host a conference call today at 4:00 PM to discuss its recent regulatory events.

The conference call will be hosted by Steven G. Anderson, President and CEO, D. Ashley Lee, Vice President and CFO, and James C. Vander Wyk, Ph.D., Vice President of Regulatory Affairs and Quality Assurance. Shareholders interested in participating in the call may do so by calling (973) 872-3100 a few minutes prior to 4:00 PM Eastern time. Those interested in listening to a replay of the teleconference may do so by calling (toll free) 877-519-4471 or (973) 341-3080. The identification number for the replay is 3443332. The replay will be available through Friday, August 16, 2002.

Founded in 1984, CryoLife, Inc. is the leader in the development and commercialization of implantable living human tissues for use in cardiovascular, vascular and orthopaedic surgeries throughout the United States and Canada. The Company's BioGlue(R) surgical adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels and is CE marked in the European Community and approved in Canada and Australia for use in vascular and pulmonary sealing and repair. The Company also manufactures the SynerGraft(R) heart valve and the SynerGraft vascular graft, the world's first tissue-engineered heart valve and vascular replacements, and the CryoLife-O'Brien(R) and CryoLife-Ross(R) stentless porcine heart valves, which are CE marked for distribution within the European Community. The human heart valves and vascular grafts processed by CryoLife using the SynerGraft technology are distributed in the U.S. under the trade names of CryoValve(R)SG and CryoVein(R)SG, respectively.

For additional information about the company, visit CryoLife's web site: http://www.cryolife.com . 

    Contact:
    D. Ashley Lee
    Vice President, Chief Financial Officer
    (800) 438-8285

                    MAKE YOUR OPINION COUNT -  Click Here
               http://tbutton.prnewswire.com/prn/11690X22115261
SOURCE CryoLife, Inc. 

CONTACT:          D. Ashley Lee, Vice President, Chief Financial Officer of
                  CryoLife, Inc., +1-800-438-8285

URL:              http://www.cryolife.com 
http://www.prnewswire.com

Copyright (C) 2002 PR Newswire.  All rights reserved.